Back

Colchicine as a therapeutic option for the treatment of pulmonary arterial hypertension (PAH) in a rat model

1 September 2024 (11:00 - 11:50)
Organised by: Logo
Congress Presentation Part of: Inflammation: novel myocardial and vascular findings Cardiac Diseases ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Robert Halmosi

University of Pecs, Pecs (Hungary)

8 More presentations in this session

Presentation thumbnail
Smooth muscle cell-specific deletion of S100A4 modifies smooth muscle cell fate and inflammation in murine atherosclerotic lesions
Doctor P. Azar (Geneva, CH)
Abstract Slides Video
Presentation thumbnail
Sex differences in the expression of metabolic and pro-inflammatory markers in the initial post-COVID-19 phase
Mr M. Estepa Martinez (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Evaluation of serum levels of sCD40, sCD40L and s4-1BB in advanced heart failure and after heart transplant
Doctor V. Monteiro (Recife, BR)
Abstract Slides Video
Presentation thumbnail
Sinomenine hydrochloride alleviates autoimmune myocarditis via suppressing Th1 cell induced-M1 macrophage pyroptosis
Doctor Z. Zhang (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Hyperlipidemia interferes with the behavior of variant NKT cells
Assistant Professor P. Shukla (Kharagpur, IN)
Abstract Slides Video

Access the full session

Session thumbnail
Inflammation: novel myocardial and vascular findings

The Event

Event poster

ESC Congress 2024

1 September 2024 11:00 CET
You may be interested in
thumbnail
Congress Presentation
EPA:DHA 6:1 prevents right ventricular dysfunction and lung vascular remodeling in monocrotaline-induced pulmonary arterial hypertension in rats by mitigating inflammatory and pro-oxidant responses
thumbnail
Congress Session
Molecular approaches to the treatment of pulmonary hypertension
thumbnail
Congress Presentation
Long-acting CRF2 receptor agonist COR-1389 improves cardiopulmonary function parameters in monocrotaline-induced pulmonary hypertension and right heart failure rat model

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources